Skip to Main Content

Author Details

Qi Chen
Lilly Research Laboratories
2006
16
8
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35333651Structural determinants of dual incretin receptor agonism by tirzepatide.Proc Natl Acad Sci U S A2022
36171189Activation of the human insulin receptor by non-insulin-related peptides.Nat Commun2022
33721487Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor.J Med Chem2021
32690941Structural insights into probe-dependent positive allosterism of the GLP-1 receptor.Nat Chem Biol2020
30470494On the origin of the 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate scaffold's unique group II selectivity for the mGlu receptors.Bioorg Med Chem Lett2019
31833461Protein Activation in Drug Discovery - Part-II.Curr Top Med Chem2019
31660833Insights into the Structural Aspects of the mGlu Receptor Orthosteric Binding Site.Curr Top Med Chem2019
31769362Protein Activation in Drug Discovery - Part-I.Curr Top Med Chem2019
31532644Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1<i>S</i>,3<i>R</i>)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor.J Med Chem2019
29350927Synthesis and Pharmacological Characterization of C4<sub>β</sub>-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2794193), a Highly Potent and Selective mGlu<sub>3</sub> Receptor Agonist.J Med Chem2018
30365309Structural Basis for ( S)-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu<sub>8</sub> Receptor.J Med Chem2018
29402739Determination of L-AP4-bound human mGlu8 receptor amino terminal domain structure and the molecular basis for L-AP4's group III mGlu receptor functional potency and selectivity.Bioorg Med Chem Lett2018
28406969Reconstruction of 3D structures of MET antibodies from electron microscopy 2D class averages.PLoS One2017
27749056The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470).J Med Chem2016
26271587Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT⿁ F receptor agonists: Evolution from bicyclic to monocyclic cores.Bioorg Med Chem Lett2015
16995730Geometric accuracy of three-dimensional molecular overlays.J Chem Inf Model2006
  • 1 - 16 of 16

Recommended Authors

Stanford University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 0
Department of Pharmaceutical Sciences, University of California San Francisco
Career Start Year 2009
Number of shared co-authors 1
Blavatnik Institute, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 1
ShanghaiTech University, China iHuman Institute
Career Start Year 2006
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 0
Uppsala University
Career Start Year 2004
Number of shared co-authors 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 3
University of North Carolina School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Monash University
Career Start Year 2000
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 2
Boston University
Career Start Year 1997
Number of shared co-authors 2
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1996
Number of shared co-authors 1
University of Dundee
Career Start Year 1995
Number of shared co-authors 1
University of New Mexico School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year 1994
Number of shared co-authors 0
The Walter and Eliza Hall Institute of Medical Research
Career Start Year 1993
Number of shared co-authors 1
University of North Carolina School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Bridge Institute, University of Southern California
Career Start Year 1991
Number of shared co-authors 0
Lilly Research Laboratories
Career Start Year 1990
Number of shared co-authors 3
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 2
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 1
iHuman Institute, ShanghaiTech University
Career Start Year 1988
Number of shared co-authors 2
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year 1986
Number of shared co-authors 0
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 0
Universite de Lorraine, CNRS
Career Start Year 1970
Number of shared co-authors 2
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 2

Collaborators

University of California san francisco
Co-authored papers 4
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Co-authored papers 4
Lilly Research Laboratories
Co-authored papers 3
Lilly Research Laboratories
Co-authored papers 1
Lilly Research Laboratories
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Lilly Research Laboratories
Co-authored papers 1
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Lilly Research Laboratories
Co-authored papers 1
The Hebrew University of Jerusalem
Co-authored papers 1
Lilly Research Laboratories
Co-authored papers 1